Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares OutstandingShares Outstanding
Ratios

Beauty Health (SKIN) Shares Outstanding (2020 - 2026)

SkinHealth Systems has reported Shares Outstanding over the past 6 years, most recently at $127.5 million for Q4 2025.

  • Quarterly Shares Outstanding rose 2.08% to $127.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.5 million through Dec 2025, up 2.08% year-over-year, with the annual reading at $127.5 million for FY2025, 2.08% up from the prior year.
  • Shares Outstanding was $127.5 million for Q4 2025 at SkinHealth Systems, roughly flat from $127.3 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $150.9 million in Q2 2022 and troughed at $35.5 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $127.4 million (2025), against an average of $127.3 million.
  • The largest YoY upside for Shares Outstanding was 324.21% in 2022 against a maximum downside of 12.21% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $150.6 million in 2021, then decreased by 12.21% to $132.2 million in 2022, then fell by 7.05% to $122.9 million in 2023, then rose by 1.65% to $124.9 million in 2024, then rose by 2.08% to $127.5 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Shares Outstanding are $127.5 million (Q4 2025), $127.3 million (Q3 2025), and $126.8 million (Q2 2025).